SMN2 and proximal spinal muscular atrophy: We have taken advantage of the Smn2B/-intermediate mouse model of SMA, which does not carry human SMN2. Here we show that TSA treatment significantly improved survival, reduced weight loss and improved motor behavior in Smn2B/- mice.